A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid...
Published in American Journal of Hematology
Dynamic follow‐up of smoldering multiple myeloma identifies a subset of patients at high risk of progression
Published in American Journal of Hematology
Transplantation of allogeneic cryopreserved hematopoietic cell grafts during the C ovid‐19 pandemic: A N ational M arrow...
Published in American Journal of Hematology
COVID‐19 will not “magically disappear”: Why Access to Widespread Testing is Paramount
...Published in American Journal of Hematology
Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism.
Published in American journal of hematology
Coagulopathy causes morbidity and mortality in patients with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Yet, the mechanisms are unclear and biomarkers are limited. Early in the pandemic, we observed markedly elevated factor V activity in a patient with COVID-19, which led us to...
A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute...
...Published in American Journal of Hematology
Oxygen gradient ektacytometry‐derived biomarkers are associated with vaso‐occlusive crises and correlate with treatment ...
...Published in American Journal of Hematology
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA / NEPHRO trials
Published in American Journal of Hematology
Association of ABO / Rh with SARS‐CoV‐2 positivity: The role of race and ethnicity in a female cohort
Published in American Journal of Hematology
Risk‐adapted therapy in follicular lymphoma: Is it time to “FLEX” ?
Published in American Journal of Hematology
